This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Integrated Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud. P.O, Thiruvananthapuram, India
E-mail: mrpillai@rgcb.res.in
; Fax: +91-(0) 471-2349303
; Tel: +91-(0) 471-2347973
Mol. BioSyst., 2011,7, 1802-1810
DOI:
10.1039/C1MB05016H
Received
15 Jan 2011,
Accepted
24 Feb 2011
First published online
24 Mar 2011
Synthetic biology concerns applying engineering principles to biological systems. Engineering properties such as fine tuning, novel specificity, and modularity could be components of a synthetic toolkit that can be exploited to explore various issues in cancer research such as elucidation of mechanisms and pathways, creating new diagnostic tools and novel therapeutic approaches. A repertoire of synthetic biology toolkits involving DNA, RNA and protein bio-parts, have been applied to address the issues of drug target identification, drug discovery and therapeutic treatment in cancer research, thereby projecting a new dimension in oncology research.
Fetching data from CrossRef. This may take some time to load.